These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

733 related articles for article (PubMed ID: 7503188)

  • 1. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
    Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
    Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas.
    Komuro H; Hayashi Y; Kawamura M; Hayashi K; Kaneko Y; Kamoshita S; Hanada R; Yamamoto K; Hongo T; Yamada M
    Cancer Res; 1993 Nov; 53(21):5284-8. PubMed ID: 8221663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid and effective detection of mutations in the p53 gene using nonradioactive single-strand conformation polymorphism (SSCP) technique applied on PhastSystem.
    Kurvinen K; Hietanen S; Syrjänen K; Syrjänen S
    J Virol Methods; 1995 Jan; 51(1):43-53. PubMed ID: 7730436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
    Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS
    Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel p53 mutation hotspot at codon 132 (AAG-->AGG) in human renal cancer.
    Dahiya R; Deng G; Selph C; Carroll P; Presti J
    Biochem Mol Biol Int; 1998 Feb; 44(2):407-15. PubMed ID: 9530523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic characterization, karyotype analysis and in vitro tamoxifen sensitivity of new ER-negative vulvar carcinoma cell lines, UM-SCV-1A and UM-SCV-1B.
    Grénman SE; Van Dyke DL; Worsham MJ; England B; McClatchey KD; Hopkins M; Babu VR; Grénman R; Carey TE
    Int J Cancer; 1990 May; 45(5):920-7. PubMed ID: 2335395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas.
    Ikenberg H; Matthay K; Schmitt B; Bauknecht T; Kiechle-Schwarz M; Göppinger A; Pfleiderer A
    Cancer; 1995 Jul; 76(1):57-66. PubMed ID: 8630877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India.
    Katiyar S; Dash BC; Thakur V; Guptan RC; Sarin SK; Das BC
    Cancer; 2000 Apr; 88(7):1565-73. PubMed ID: 10738214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour suppressor p53 and Rb genes in human hepatocellular carcinoma.
    Lin Y; Shi CY; Li B; Soo BH; Mohammed-Ali S; Wee A; Oon CJ; Mack PO; Chan SH
    Ann Acad Med Singap; 1996 Jan; 25(1):22-30. PubMed ID: 8779541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 mutations and clonality in vulvar carcinomas and squamous hyperplasias: evidence suggesting that squamous hyperplasias do not serve as direct precursors of human papillomavirus-negative vulvar carcinomas.
    Kim YT; Thomas NF; Kessis TD; Wilkinson EJ; Hedrick L; Cho KR
    Hum Pathol; 1996 Apr; 27(4):389-95. PubMed ID: 8617483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new mutational hot-spot in the p53 gene in human hepatocellular carcinoma.
    Diamantis ID; McGandy C; Chen TJ; Liaw YF; Gudat F; Bianchi L
    J Hepatol; 1994 Apr; 20(4):553-6. PubMed ID: 8051396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of mutations in exon 7 of p53 from fresh tumor samples by single-strand conformation polymorphism and direct DNA sequencing].
    Zhang X; Fu Y; Liu S; Liang C
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Apr; 36(2):142-5. PubMed ID: 12761985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of the p53 gene in oral squamous-cell carcinomas from Sudanese dippers of nitrosamine-rich toombak and non-snuff-dippers from the Sudan and Scandinavia.
    Ibrahim SO; Vasstrand EN; Johannessen AC; Idris AM; Magnusson B; Nilsen R; Lillehaug JR
    Int J Cancer; 1999 May; 81(4):527-34. PubMed ID: 10225439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A non-random deletion in the p53 gene in oral squamous cell carcinoma.
    Nylander K; Schildt EB; Eriksson M; Magnusson A; Mehle C; Roos G
    Br J Cancer; 1996 Jun; 73(11):1381-6. PubMed ID: 8645583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue.
    Sarkar FH; Valdivieso M; Borders J; Yao KL; Raval MM; Madan SK; Sreepathi P; Shimoyama R; Steiger Z; Visscher DW
    Diagn Mol Pathol; 1995 Dec; 4(4):266-73. PubMed ID: 8634783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
    Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
    Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of p53 mutations between adenocarcinoma and squamous cell carcinoma of the lung: unique spectra involving G to A transitions and G to T transversions in both histologic types.
    Gao WM; Mady HH; Yu GY; Siegfried JM; Luketich JD; Melhem MF; Keohavong P
    Lung Cancer; 2003 May; 40(2):141-50. PubMed ID: 12711114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of proliferation of UM-SCV-1A and UM-SCV-6 vulvar carcinoma cells by cytokines.
    Vihko KK; Seppänen M; Henttinen T; Punnonen J; Grénman S; Punnonen R
    Cancer Immunol Immunother; 1997 Jan; 43(6):368-74. PubMed ID: 9067409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of the p53 gene in human functional adrenal neoplasms.
    Lin SR; Lee YJ; Tsai JH
    J Clin Endocrinol Metab; 1994 Feb; 78(2):483-91. PubMed ID: 8106638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas.
    Fagin JA; Matsuo K; Karmakar A; Chen DL; Tang SH; Koeffler HP
    J Clin Invest; 1993 Jan; 91(1):179-84. PubMed ID: 8423216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.